Testosterone potentiated32P therapy in prostatic carcinoma
- 1 August 1966
- Vol. 19 (8) , 1088-1090
- https://doi.org/10.1002/1097-0142(196608)19:8<1088::aid-cncr2820190806>3.0.co;2-o
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Evaluation of Phosphorus 32 for Intractable Pain Secondary to Prostatic Carcinoma MetastasesJAMA, 1965
- Erythropoietic Effect of Plasma from Mice receiving TestosteroneNature, 1965
- Experiences With P-32 in the Treatment of Metastatic Carcinoma of the Prostate: A Followup ReportJournal of Urology, 1962
- Androgens and ErythropoiesisArchives of internal medicine (1960), 1961
- Experiences with P-32 in Treatment of Metastatic Carcinoma of Prostate: a Preliminary ReportJournal of Urology, 1961
- MANAGEMENT OF DIFFUSE METASTASIS FROM CARCINOMA OF THE PROSTATEJAMA, 1960
- The Use of Radioactive Phosphorus and Testosterone in Metastatic Bone Lesions from Breast and ProstateSouthern Medical Journal, 1958
- Tracer Studies with Radioactive Phosphorus in Malignant Neoplastic DiseaseRadiology, 1941
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941